Show results for
Refine by
Neurology Disease Suppliers In Usa
40 companies found
based inRye Brook, NEW YORK (USA)
Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Our pipeline includes our lead drug candidate, CM-AT, which is in a Phase III clinical trial for Autism, and is ...
based inWashington, DISTRICT OF COLUMBIA (USA)
We’re pioneering precision neurology by building the world’s leading platform for reliable, accessible, affordable diagnosis and monitoring of neurological diseases. At Altoida, we recognize the need for individuals to understand their brain health ...
based inBrisbane, CALIFORNIA (USA)
Sangamo is a genomic medicine company that seeks to help millions of people who suffer from severe diseases for which today’s medicine can only offer symptom management at best. Our mission is to translate ground-breaking science into medicines that ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
based inCleveland, OHIO (USA)
about-us-imageNDI (Neuro Device Innovations) is a hybrid venture capital and commercialization firm focusing exclusively on innovative neurodevice technologies. NDI pursues, funds and develops opportunities that address unmet clinical needs with ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat produces a relapsing-remitting ...
based inSt. Louis, MISSOURI (USA)
C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...
based inOak Creek, WISCONSIN (USA)
Ad-Tech was founded in 1983 by a visionary and parent who knew first-hand how devastating neurological disease can be. Since then, we’ve had a singular focus on designing, engineering and supporting the world’s most sought-after devices. Surgeons, ...
based inMontclair, NEW JERSEY (USA)
Theranica develops advanced, clinically proven, safe and affordable digital therapeutics, addressing some of the world’s most prevalent neurological pain diseases. We harness a pain inhibition mechanism known as Conditioned Pain Modulation (CPM). ...
based inRueil-Malmaison Cedex, FRANCE
At Advanced Accelerator Applications (AAA), we are reimagining nuclear medicine and cancer care. Our mission is to transform patients’ lives by developing and delivering targeted radioligand therapies and precision imaging radioligands for oncology. ...
AAA brand names for FDG (most widely used PET tracer): Oncology, cardiology, neurology. Infectious and inflammatory ...
based inMonterey, CALIFORNIA (USA)
Vybion has pioneered vectorized Intrabodies, the delivery of functional antibody fragments in the scFv format to cells using Adeno associated virus (AAV). The Company has Orphan Drug Designation from the FDA for INT41 to treat Huntington’s disease a ...
based inPhoenix, ARIZONA (USA)
nVector enables and accelerates breakthrough treatments for previously untreatable diseases of the central nervous system. Iron Horse Diagnostics, Inc. is a privately held molecular diagnostic company focused on the development and commercialization ...
These tests are quite valuable to be included in a biomarker “tool kit” that can be used for multiple neurologic diseases, as they measure activation of cell types that cause inflammation in the ...
based inShanghai, CHINA
RareStone Group is dedicated to building the first rare disease ecosystem in China to improve the lives of patients and families impacted by rare diseases, by bringing the best-in-the-world therapeutic solutions and comprehensive and sustainable ...
Rare neurological diseases include developmental defects of the nervous system, genetic and metabolic diseases, neuroimmune diseases, neurological tumors, special ...
based inMadison, WISCONSIN (USA)
BrainXell was founded in 2015 by Prof. Su-Chun Zhang in conjunction with the Discovery to Product (D2P) program of University of Wisconsin- Madison and operates out of a new facility in University Research Park. The company is based on the ...
based inMinnetonka, MINNESOTA (USA)
Monteris Medical was founded in 1999 with the sole focus to help patients suffering from neurological diseases. The company’s goal remains: to create a minimally invasive surgical option for use in the brain. Monteris is a private equity backed ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
based inIndianapolis, INDIANA (USA)
Drug Free Therapeutix (DFTx) provides intelligent software for medical device companies in or entering the lucrative $4BB pain management device market. Our platform technology, known as Extraneural Activation Control Technology (EXACT), fine-tunes ...
based inMaplewood, MINNESOTA (USA)
WR Medical Electronics Co. is a privately-held company located near St. Paul Minnesota. Our customers around the world have enjoyed our quality products and superior service since 1962. It has been our privilege to collaborate with world-renowned ...
based inInglewood, CALIFORNIA (USA)
ProteoGenex is an established, innovative provider of biological specimens and clinical information of the highest quality standards. We are a privately held US company founded in Los Angeles, CA in 2003. With headquarters in Los Angeles, CA, we ...
based inPearl River, NEW YORK (USA)
Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a ...